PMC:7105881 / 35094-35293
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T199 | 33-40 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T191 | 47-51 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T192 | 138-142 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T202 | 33-40 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32265848-17049691-36511146 | 173-177 | 17049691 | denotes | 2007 |
32265848-22311359-36511147 | 193-197 | 22311359 | denotes | 2012 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T206 | 0-199 | Sentence | denotes | Different from the full-length S protein-based SARS subunit vaccines, no obvious pathogenic effects have been identified in the RBD-based SARS subunit vaccines (Kam et al., 2007; Jaume et al., 2012). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T597 | 31-40 | PG_1 | denotes | S protein |
T598 | 47-51 | SP_10 | denotes | SARS |
T599 | 138-142 | SP_10 | denotes | SARS |
T73954 | 31-40 | PG_1 | denotes | S protein |
T20931 | 47-51 | SP_10 | denotes | SARS |
T28537 | 138-142 | SP_10 | denotes | SARS |